{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:17:57Z","timestamp":1782105477250,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T00:00:00Z","timestamp":1489622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471535"],"award-info":[{"award-number":["81471535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS075887"],"award-info":[{"award-number":["R01NS075887"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS76013"],"award-info":[{"award-number":["R01NS76013"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI122574"],"award-info":[{"award-number":["AI122574"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11011-017-9991-6","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T08:27:59Z","timestamp":1489652879000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["DR\u03b11-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury"],"prefix":"10.1007","volume":"32","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siman","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Meza-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Benedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A","family":"Vandenbark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Offner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,16]]},"reference":[{"key":"9991_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153418","volume":"11","author":"HS Basrai","year":"2016","unstructured":"Basrai HS, Christie KJ, Turbic A, Bye N, Turnley AM (2016) Suppressor of cytokine signaling-2 (SOCS2) regulates the microglial response and improves functional outcome after traumatic brain injury in mice. PLoS One 11:e0153418. doi:\n                    10.1371\/journal.pone.0153418","journal-title":"PLoS One"},{"key":"9991_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11011-013-9440-0","volume":"29","author":"G Benedek","year":"2014","unstructured":"Benedek G et al (2014) A novel HLA-DRalpha1-MOG-35-55 construct treats experimental stroke. Metab Brain Dis 29:37\u201345. doi:\n                    10.1007\/s11011-013-9440-0","journal-title":"Metab Brain Dis"},{"key":"9991_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2016.10.007","author":"G Benedek","year":"2016","unstructured":"Benedek G, Vandenbark AA, Alkayed NJ, Offner H (2016) Partial MHC class II constructs as novel immunomodulatory therapy for stroke. Neurochem Int. doi:\n                    10.1016\/j.neuint.2016.10.007","journal-title":"Neurochem Int"},{"key":"9991_CR4","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.4049\/jimmunol.167.8.4386","volume":"167","author":"GG Burrows","year":"2001","unstructured":"Burrows GG et al (2001) Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J Immunol 167:4386\u20134395","journal-title":"J Immunol"},{"key":"9991_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaneurol.2014.3558","volume":"72","author":"KN Corps","year":"2015","unstructured":"Corps KN, Roth TL, McGavern DB (2015) Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 72:355\u2013362. doi:\n                    10.1001\/jamaneurol.2014.3558","journal-title":"JAMA Neurol"},{"key":"9991_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11011-011-9241-2","volume":"26","author":"S Dziennis","year":"2011","unstructured":"Dziennis S et al (2011) Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis 26:123\u2013133. doi:\n                    10.1007\/s11011-011-9241-2","journal-title":"Metab Brain Dis"},{"key":"9991_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.bbi.2012.06.008","volume":"26","author":"A Kumar","year":"2012","unstructured":"Kumar A, Loane DJ (2012) Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 26:1191\u20131201. doi:\n                    10.1016\/j.bbi.2012.06.008","journal-title":"Brain Behav Immun"},{"key":"9991_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fimmu.2016.00556","volume":"7","author":"CA McKee","year":"2016","unstructured":"McKee CA, Lukens JR (2016) Emerging roles for the immune system in traumatic brain injury. Front Immunol 7:556. doi:\n                    10.3389\/fimmu.2016.00556","journal-title":"Front Immunol"},{"key":"9991_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106238","volume":"9","author":"Y Meng","year":"2014","unstructured":"Meng Y, Chopp M, Zhang Y, Liu Z, An A, Mahmood A, Xiong Y (2014) Subacute intranasal administration of tissue plasminogen activator promotes neuroplasticity and improves functional recovery following traumatic brain injury in rats. PLoS One 9:e106238. doi:\n                    10.1371\/journal.pone.0106238","journal-title":"PLoS One"},{"key":"9991_CR10","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.4049\/jimmunol.1303118","volume":"192","author":"R Meza-Romero","year":"2014","unstructured":"Meza-Romero R et al (2014) HLA-DRalpha1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis. J Immunol 192:4164\u20134173. doi:\n                    10.4049\/jimmunol.1303118","journal-title":"J Immunol"},{"key":"9991_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11011-016-9798-x","volume":"31","author":"R Meza-Romero","year":"2016","unstructured":"Meza-Romero R, Benedek G, Leng L, Bucala R, Vandenbark AA (2016) Predicted structure of MIF\/CD74 and RTL1000\/CD74 complexes. Metab Brain Dis 31:249\u2013255. doi:\n                    10.1007\/s11011-016-9798-x","journal-title":"Metab Brain Dis"},{"key":"9991_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-014-0345-y","author":"J Pan","year":"2014","unstructured":"Pan J et al (2014) Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke. Transl Stroke Res. doi:\n                    10.1007\/s12975-014-0345-y","journal-title":"Transl Stroke Res"},{"key":"9991_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12975-011-0126-9","volume":"2","author":"V Pop","year":"2011","unstructured":"Pop V, Badaut J (2011) A neurovascular perspective for long-term changes after brain trauma. Transl Stroke Res 2:533\u2013545. doi:\n                    10.1007\/s12975-011-0126-9","journal-title":"Transl Stroke Res"},{"key":"9991_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1750-3639.2004.tb00056.x","volume":"14","author":"R Raghupathi","year":"2004","unstructured":"Raghupathi R (2004) Cell death mechanisms following traumatic brain injury. Brain Pathol 14:215\u2013222","journal-title":"Brain Pathol"},{"key":"9991_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ana.22455","volume":"70","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF et al (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70:374\u2013383. doi:\n                    10.1002\/ana.22455","journal-title":"Ann Neurol"},{"key":"9991_CR16","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1161\/STROKEAHA.108.543991","volume":"40","author":"S Subramanian","year":"2009","unstructured":"Subramanian S et al (2009) Recombinant T cell receptor ligand treats experimental stroke. Stroke; a journal of cerebral circulation 40:2539\u20132545. doi:\n                    10.1161\/STROKEAHA.108.543991","journal-title":"Stroke; a journal of cerebral circulation"},{"key":"9991_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s40478-014-0143-5","volume":"2","author":"RP Tobin","year":"2014","unstructured":"Tobin RP et al (2014) Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration. Acta Neuropathol Commun 2:143. doi:\n                    10.1186\/s40478-014-0143-5","journal-title":"Acta Neuropathol Commun"},{"key":"9991_CR18","doi-asserted-by":"publisher","first-page":"22315","DOI":"10.1038\/srep22315","volume":"6","author":"H Tsukano","year":"2016","unstructured":"Tsukano H, Horie M, Hishida R, Takahashi K, Takebayashi H, Shibuki K (2016) Quantitative map of multiple auditory cortical regions with a stereotaxic fine-scale atlas of the mouse brain. Scientific reports 6:22315. doi:\n                    10.1038\/srep22315","journal-title":"Scientific reports"},{"key":"9991_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaut.2012.08.004","volume":"40","author":"AA Vandenbark","year":"2013","unstructured":"Vandenbark AA et al (2013) A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance. J Autoimmun 40:96\u2013110. doi:\n                    10.1016\/j.jaut.2012.08.004","journal-title":"J Autoimmun"},{"key":"9991_CR20","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.4049\/jimmunol.171.4.1934","volume":"171","author":"C Wang","year":"2003","unstructured":"Wang C et al (2003) Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation. J Immunol 171:1934\u20131940","journal-title":"J Immunol"},{"key":"9991_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-016-0514-2","author":"J Wang","year":"2016","unstructured":"Wang J et al (2016) DRalpha1-MOG-35-55 reduces permanent ischemic brain injury. Transl Stroke Res. doi:\n                    10.1007\/s12975-016-0514-2","journal-title":"Transl Stroke Res."},{"key":"9991_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-014-0348-8","author":"W Zhu","year":"2014","unstructured":"Zhu W, Libal NL, Casper A, Bodhankar S, Offner H, Alkayed NJ (2014) Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke. Transl Stroke Res. doi:\n                    10.1007\/s12975-014-0348-8","journal-title":"Transl Stroke Res."},{"key":"9991_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12975-014-0373-7","volume":"6","author":"W Zhu","year":"2015","unstructured":"Zhu W, Casper A, Libal NL, Murphy SJ, Bodhankar S, Offner H, Alkayed NJ (2015) Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke. Translational stroke research 6:60\u201368. doi:\n                    10.1007\/s12975-014-0373-7","journal-title":"Translational stroke research"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-017-9991-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-9991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-017-9991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T10:16:23Z","timestamp":1589710583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-017-9991-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["9991"],"URL":"https:\/\/doi.org\/10.1007\/s11011-017-9991-6","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]},"assertion":[{"value":"31 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was supported in part by the National Science Foundation of China grant 81,471,535 (to ML); US National Institutes of Health grants R01NS092713 (to HO) and AI 122574 (to AAV); Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Drs. Vandenbark, Offner, Benedek, Meza-Romero and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VA Portland Health Care System Conflict of Interest in Research Committees. The other authors (Liu Yang, Zhijia Liu, Honglei Ren, Lei Zhang, Siman Gao, Li Ren, Zhi Chai, and Minshu Li) declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}